Director Dealings

Transactions

Dealing dateCompany / TickerName / TitleSharesPer shareDeal size
Purchase25 Jun 2025Centrica PLCCNA:LSEPhilippe Francois Marie-Joseph BoisseauNon-Executive Director1,0161.66
GBP
1.68k GBP
Purchase25 Jun 2025Poolbeg Pharma PLCPOLB:LSECathal Martin FrielExecutive Director,Chairman4,000,0000.025
GBP
100.00k GBP
Purchase24 Jun 2025Public Policy Holding Company IncPPHC:LSEGeorge Stewart HallExecutive Director,Chief Executive Officer100,0001.41
USD
140.50k USD
Purchase24 Jun 2025Public Policy Holding Company IncPPHC:LSEZachary Wayne WilliamsExecutive Director13,3331.41
USD
18.73k USD
Purchase24 Jun 2025Public Policy Holding Company IncPPHC:LSERoeland Jozef Bernard SmitsExecutive Director,Chief Financial Officer23,2431.41
USD
32.66k USD
Purchase24 Jun 2025Public Policy Holding Company IncPPHC:LSEKeenan Austin ReedExecutive Director13,3891.41
USD
18.81k USD
Sale24 Jun 2025UiPath IncPATH:NYQDaniel DinesChairman of the Board and Chief Executive Officer45,00012.49
USD
561.94k USD
Sale24 Jun 2025Extreme Networks IncEXTR:NSQRajendra KhannaIndependent Director2,02717.43
USD
35.34k USD
Purchase24 Jun 2025Texas Pacific Land CorpTPL:NYQMurray StahlIndependent Director21,039.48
USD
2.08k USD
Purchase24 Jun 2025Hurco Companies IncHURC:NSQMichael DoarExecutive Chairman of the Board2,00015.99
USD
31.98k USD
Sale24 Jun 2025Halozyme Therapeutics IncHALO:NSQHelen I. TorleyDirector, President and Chief Executive Officer4,48953.11
USD
238.41k USD
Sale24 Jun 2025Halozyme Therapeutics IncHALO:NSQHelen I. TorleyDirector, President and Chief Executive Officer15,51153.91
USD
836.21k USD
Purchase24 Jun 2025Texas Pacific Land CorpTPL:NYQMurray StahlIndependent Director31,039.48
USD
3.12k USD
Purchase24 Jun 2025Texas Pacific Land CorpTPL:NYQMurray StahlIndependent Director21,039.48
USD
2.08k USD
Sale24 Jun 2025Arlo Technologies IncARLO:NYQMatthew McRaeChief Executive Officer and Director305,20416.80
USD
5.13m USD
24251 total results
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.